The Molecular Biology of Myeloma
David S. Siegel, MD, PhD
Video Categories: Targeted Therapies
Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.
In this next segment, Dr Agarwala discusses when and how molecular tests should be utilized.